Log In
BCIQ
Print this Print this
 

URMC-214

  Manage Alerts
Collapse Summary General Information
Company WavoDyne Therapeutics Inc.
DescriptionSelective peripheral mixed-lineage kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationHeart failure
Indication DetailsTreat heart failure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today